CDSCO Panel approves Eli Lilly proposal to Increase patients number from India 37 to 57 for LY3871801 study Dr. Divya Colin5 May 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved pharmaceutical...
CDSCO Panel Approves Eli Lilly's Protocol Amendment proposal to study Anti-cancer Drug LY3537982 Dr. Divya Colin10 Jan 2025 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
Eli Lilly gets CDSCO Panel nod to modify prescription warning for Insulin Lispro Ultrarapid Injection Dr. Divya Colin25 Nov 2024 5:15 PM ISTNew Delhi: In line with the proposal for amending the warning statement of Insulin Lispro Ultrarapid Injection 100 IU & 200 IU, the Subject Expert...
Eli Lilly Company Gets CDSCO Panel Nod To Import, Market Antidiabetic drug Tirzepatide for chronic weight management Dr. Divya Colin3 July 2024 6:00 PM ISTNew Delhi: The drug major Eli Lily Company India has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Eli Lilly Gets CDSCO Panel Nod to Study Lepodisiran Dr. Divya Colin25 April 2024 6:00 PM ISTNew Delhi: The drug major Eli Lilly has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel Approves Eli Lilly's protocol amendment proposal for Adjuvant Imlunestrant vs Standard Adjuvant study Dr. Divya Colin21 April 2024 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major Eli...
Eli Lilly gets CDSCO Panel Nod to Import, Market Antidiabetic Drug Tirzepatide solution for injection Single dose vial Dr. Divya Colin29 Feb 2024 6:00 PM ISTNew Delhi: The drug major Eli Lilly has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Eli Lilly concludes acquisition of POINT Biopharma Ruchika Sharma28 Dec 2023 12:30 PM ISTIndianapolis: Eli Lilly and Company has announced the successful completion of its acquisition of POINT Biopharma Global Inc., a...
